Cargando…

Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis

An improved number of anti-fungal drugs are currently available for the treatment of invasive aspergillosis (IA). While serial galactomannan index (GMI) measurement can be used to monitor response to treatment, the extent to which different anti-fungal regimens can affect galactomannan levels is unk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chai, Louis Yi Ann, Kullberg, Bart Jan, Earnest, Arul, Johnson, Elizabeth M., Teerenstra, Steven, Vonk, Alieke G., Schlamm, Haran T., Herbrecht, Raoul, Netea, Mihai G., Troke, Peter F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938651/ https://www.ncbi.nlm.nih.gov/pubmed/24587262 http://dx.doi.org/10.1371/journal.pone.0090176

Ejemplares similares

Serum galactomannan levels in the diagnosis of invasive aspergillosis
por: Okuturlar, Yildiz, et al.
Publicado: (2015)

Invasive Pulmonary Aspergillosis
por: Ledoux, Marie-Pierre, et al.
Publicado: (2023)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Successful Treatment of Antifungal Combination Therapy with Inhaled Liposomal Amphotericin B and Oral Voriconazole for Intractable Chronic Progressive Pulmonary Aspergillosis
por: Hamada, Noboru, et al.
Publicado: (2021)

Efficacy of voriconazole and amphotericin B in corneal preservative media
por: Das, Sujata, et al.
Publicado: (2022)

Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
por: Cao, Xun-Jie, et al.
Publicado: (2020)

Sputum Galactomannan Has Utility in the Diagnosis of Chronic Pulmonary Aspergillosis
por: Nuh, Ali, et al.
Publicado: (2022)

Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain
por: Ostermann, Helmut, et al.
Publicado: (2014)

Comparing Invasive Pulmonary Aspergillosis Mortality Between Liposomal Amphotericin B and Voriconazole in Patients With Hematological Malignancy or Hematopoietic Stem Cell Transplantation
por: Mahmoud, Ebrahim, et al.
Publicado: (2022)

Amphotericin-B-liposomal/voriconazole: Renal impairment: case report
Publicado: (2021)

Orbital Aspergillosis: Voriconazole – The New Standard Treatment?
por: Ohlstein, Derek H., et al.
Publicado: (2012)

A Mortality Prediction Rule for Hematology Patients with Invasive Aspergillosis Based on Serum Galactomannan Kinetics
por: Mercier, Toine, et al.
Publicado: (2020)

Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes
por: Baddley, John W, et al.
Publicado: (2013)

Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis
por: Román-Montes, Carla M., et al.
Publicado: (2022)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
por: Efe İris, Nur, et al.
Publicado: (2016)

1639. Efficacy of Voriconazole Prophylaxis Followed by Therapeutic Liposomal Amphotericin B for the Treatment of Murine Pulmonary Aspergillosis Caused by Azole-Resistant Aspergillus fumigatus Strains
por: Olson, Jon, et al.
Publicado: (2018)

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
por: Sarfati, Sacha, et al.
Publicado: (2022)

747. Diagnostic Performance of Bronchoalveolar Lavage Fluid Galactomannan Assay in Patients with Negative Serum Galactomannan Assay Suspected with Invasive Pulmonary Aspergillosis
por: Lim, So Yun, et al.
Publicado: (2020)

Pharmacology and metabolism of voriconazole and posaconazole in the treatment of invasive aspergillosis-review of the literature
por: Sandherr, M, et al.
Publicado: (2011)

Detection of Urinary Excreted Fungal Galactomannan-like Antigens for Diagnosis of Invasive Aspergillosis
por: Dufresne, Simon F., et al.
Publicado: (2012)

Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis
por: Lamoth, Frédéric
Publicado: (2016)

Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age
por: Mercier, Toine, et al.
Publicado: (2018)

Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients
por: Zhuang, Qidong, et al.
Publicado: (2017)

Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials
por: Kullberg, Bart Jan, et al.
Publicado: (2017)

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
por: Marks, David I, et al.
Publicado: (2011)

Refractory Scedosporium apiospermum Keratitis Successfully Treated with Combination of Amphotericin B and Voriconazole
por: Fadzillah, Mohd-Tahir, et al.
Publicado: (2013)

Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report
por: Akers, Kevin S, et al.
Publicado: (2015)

Filamentous fungal endophthalmitis: results of combination therapy with intravitreal amphotericin B and voriconazole
por: Mithal, Kopal, et al.
Publicado: (2015)

Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis
por: Serraj, Khalid, et al.
Publicado: (2020)

Amphotericin-B-liposomal/isavuconazole/voriconazole: Lack of efficacy: 6 case report
Publicado: (2022)

Management of invasive aspergillosis in patients with COPD: Rational use of voriconazole
por: Ader, Florence, et al.
Publicado: (2009)

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial
por: Cadranel, J., et al.
Publicado: (2012)

Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis
por: Han, Seung Beom, et al.
Publicado: (2015)

The Diagnosis of Invasive and Noninvasive Pulmonary Aspergillosis by Serum and Bronchoalveolar Lavage Fluid Galactomannan Assay
por: Zhang, Shuzhen, et al.
Publicado: (2015)

Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosis
por: Khodavaisy, S, et al.
Publicado: (2015)

Long-Term Kinetics of Serum Galactomannan during Treatment of Complicated Invasive Pulmonary Aspergillosis
por: Tragiannidis, Athanasios, et al.
Publicado: (2023)

P424 Comparative analysis of Galactomannan Lateral Flow Assay, Galactomannan Enzyme Immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis
por: Hedayati, Mohammad, et al.
Publicado: (2022)

A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis
por: Ferguson, Martin J, et al.
Publicado: (2017)

Amphotericin-B liposomal/voriconazole: Drug induced liver injury and hypokalaemia: case report
Publicado: (2021)

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
por: Karthaus, M
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4nbmiibo2i4okqdorpi39nj8r7